Healthcare+ Expo Taiwan 2025 Sets Records with AI Focus and Major International Deals
Czech Health Technology Institute Signs €200 million Procurement MOU
The 2025 Healthcare+ Expo Taiwan (台灣醫療科技展) was held from December 4 to 7, marking its ninth year with record-breaking scale and significant international announcements. The exhibition has established itself as the largest medical technology platform in the Asia-Pacific region, with a strategic focus on integrating AI into medicine platforms and medical AI robotics.
Exhibition Scale and Global Reach
The expo’s scale has expanded dramatically from its initially planned 700 booths to 2,100 booths this year, featuring over 650 participating institutions from Taiwan and abroad. The event showcased the strong international appeal of Taiwan’s medical technology, welcoming:
45 overseas delegations.
31 international industry associations.
9 hospital organizations.
A total of 320 corporate members and 130 hospital leaders.
The market expansion of Taiwan’s medical technology now extends from Southeast Asia to the Middle East, Europe, North America, and, recently, Africa and South America. This confirms the highly competitive nature of Taiwanese products and signifies the domestic health industry’s substantive entry into the global supply chain.
Record-Breaking Czech Procurement Deal
A major announcement was made on the opening day, setting a new high for international matchmaking at the expo. The Czech Health Technology Institute (CHTI) and the Institute for Biotechnology and Medicine Industry (IBMI, the organizer) signed a Memorandum of Understanding for a procurement project with a total plan value of up to €200 million (approximately US$233 million).
Deal Details:
Purpose: To strengthen basic healthcare, maternal and child care, and the resilience of regional and central hospitals in Sub-Saharan African countries.
Background: CHTI is a non-profit organization established in 2021. The collaboration began in 2023, with several Taiwanese smart medical products (such as handheld ultrasounds, immunoassay analyzers, medical tablets, and operating tables) already entering the Eastern European market due to their innovation and quality.
Items Procured: Approximately 20 items, including respiratory devices for intensive care units, patient life monitoring equipment, and fetal electrocardiogram monitors.
Role of IBMI: The Institute will consolidate and submit Taiwanese products that comply with EU and Czech regulations.
IBMI Chairman Weng Chi-Huey (翁啟惠) stated that this cross-border, cross-continent procurement deal further enhances the international attraction of Taiwan’s medical technology, helping the industry truly go global.
Focus on AI and Innovation
The exhibition highlighted Taiwan’s unique advantage in the AI era, stemming from its global position in servers, chip manufacturing, supercomputers, and computing power deployment. This capability creates a “trinity” of manufacturing power, computing power, and medical AI, which is the core engine for the next wave of healthcare revolution.
Top 10 Innovative Medical Products of the Year
To help international buyers select products, the organizers announced the “Top 10 Innovative Medical Technology Products”:
In addition to AI platforms, the exhibit featured over 10 medical robots that have been commercially launched and implemented in clinics, covering surgical navigation, in-hospital care, rehabilitation training, and smart logistics.
Elevating Medical Quality Standards: SNQ and ICHOM Partnership
The Asia Pacific Healthcare Quality Annual Conference, held alongside the expo, saw the signing of a cooperation agreement between Taiwan’s SNQ National Quality Mark and the International Consortium for Health Outcomes Measurement (ICHOM).
Significance: Taiwan’s original SNQ quality certification mechanism officially became ICHOM’s first partner in Asia.
Integration: The mature SNQ quality certification mechanism will integrate ICHOM’s renowned Patient-Reported Outcome Measures (PROMs) standard. PROMs—which collect standardized questionnaires to understand patients’ subjective feelings about quality of life and functional recovery—is used by dozens of top medical centers globally, including the Mayo Clinic and Johns Hopkins.
Impact: This collaboration connects Taiwan’s quality system with international standards, enhancing the global visibility of Taiwan’s medical quality. Starting in 2024, PROMs have become a key metric for Newsweek‘s World’s Best Hospitals rankings.
Since its founding in 1998, SNQ has certified over 2,900 cross-disciplinary projects. Its rigorous three-stage evaluation system has identified 16 international leading achievements by Taiwanese medical teams, which have helped rewrite global standard treatment guidelines.